Connection

David Potter to Eye

Back to Details
This is a "connection" page, showing publications David Potter has written about Eye.
David Potter
Connection Strength
1.608
Eye
  1. The opioidergic system: potential roles and therapeutic indications in the eye. J Ocul Pharmacol Ther. 2008 Apr; 24(2):117-40.
    View in: PubMed
    Score: 0.282
  2. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology. 2002 Jul; 65(3):155-61.
    View in: PubMed
    Score: 0.189
  3. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides. 2001 Oct-Dec; 35(5-6):232-7.
    View in: PubMed
    Score: 0.180
  4. Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonist. J Pharmacol Exp Ther. 2000 Jun; 293(3):710-6.
    View in: PubMed
    Score: 0.164
  5. Ocular actions of moxonidine: a possible role for imidazoline receptors. J Pharmacol Exp Ther. 1994 Jun; 269(3):897-904.
    View in: PubMed
    Score: 0.108
  6. Ocular actions of an octahydrobenzo[f]quinoline: Ha117. Eur J Pharmacol. 1993 May 12; 236(1):61-8.
    View in: PubMed
    Score: 0.100
  7. Functional evidence for heterogeneity of ocular alpha 2-adrenoceptors. Proc West Pharmacol Soc. 1990; 33:257-60.
    View in: PubMed
    Score: 0.080
  8. Ocular and cardiac beta-antagonism by timolol prodrugs, timolol and levobunolol. Curr Eye Res. 1988 Aug; 7(8):755-9.
    View in: PubMed
    Score: 0.072
  9. LY141865: a relatively selective DA2 agonist with complex ocular activity. J Ocul Pharmacol. 1988; 4(1):19-28.
    View in: PubMed
    Score: 0.069
  10. Ocular effects of a N,N-disubstituted 5-OH aminotetralin (N-0437): evidence for a dual mechanism of action. Curr Eye Res. 1987 Nov; 6(11):1319-26.
    View in: PubMed
    Score: 0.069
  11. Aporphine derivatives affect ocular function in diverse ways. Curr Eye Res. 1987 Oct; 6(10):1227-36.
    View in: PubMed
    Score: 0.068
  12. Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys. Curr Eye Res. 1986 Sep; 5(9):665-76.
    View in: PubMed
    Score: 0.063
  13. Forskolin suppresses sympathetic neuron function and causes ocular hypotension. Curr Eye Res. 1985 Feb; 4(2):87-96.
    View in: PubMed
    Score: 0.057
  14. Steric structure activity relationships of various adrenergic agonists: ocular and systemic effects. Curr Eye Res. 1981; 1(1):25-35.
    View in: PubMed
    Score: 0.043
  15. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. J Pharmacol Exp Ther. 1993 Nov; 267(2):822-7.
    View in: PubMed
    Score: 0.026
  16. Mechanism of the ocular hypotensive action of ketanserin. J Ocul Pharmacol. 1985; 1(2):137-47.
    View in: PubMed
    Score: 0.014
  17. Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment. Curr Eye Res. 1984 Feb; 3(2):307-14.
    View in: PubMed
    Score: 0.013
  18. Adrenergic drugs and intraocular pressure. Gen Pharmacol. 1981; 12(1):1-13.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.